SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
4.880
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
4.885
+0.005 (0.10%)
After-hours: Apr 28, 2026, 7:54 PM EDT
SLS Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SLS stock has a target of 10, which predicts an increase of 104.92% from the current stock price of 4.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 12, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for SLS is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +104.92% | Mar 12, 2026 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +43.44% | Jul 16, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -38.52% | Nov 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | -38.52% | Sep 7, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +63.93% | Nov 15, 2022 |
Financial Forecast
Revenue This Year
21.90M
Revenue Next Year
46.20M
from 21.90M
Increased by 110.98%
EPS This Year
-0.25
from -0.25
EPS Next Year
-0.24
from -0.25
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 22.8M | 49.6M | ||||
| Avg | 21.9M | 46.2M | ||||
| Low | 21.2M | 43.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | 126.5% | ||||
| Avg | - | 111.0% | ||||
| Low | - | 98.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.21 | -0.23 | ||||
| Avg | -0.25 | -0.24 | ||||
| Low | -0.29 | -0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.